OCTAGAM Side Effects

7046864-7 | Apnoea, Arthralgia, Asthenia, Blood Pressure Increased, Deep Vein Thrombosis, Fatigue, Infusion Related Reaction, Oxygen Saturation Decreased, Respiratory Failure
on Aug 26, 2010 Male patient from UNITED STATES , 62 years of age, was diagnosed with demyelinating polyneuropathy and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: apnoea, arthralgia, asthenia, blood pressure increased, deep vein thrombosis (What is deep vein thrombosis?), fatigue, infusion related reaction, oxygen saturation decreased, respiratory failure. Octagam dosage: 60gm X 2 Days As Needed. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SINGULAIR (View Singulair Review and Singulair Label ), LOPRESSOR (METROPROLOL) (View Lopressor (metroprolol) Review and Lopressor (metroprolol) Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

7046857-X | Hepatitis B Antibody Positive, Transmission Of An Infectious Agent Via A Medicinal Product
Patient was taking Octagam (View Usage). Patient had the following side effects: hepatitis b antibody positive, transmission of an infectious agent via a medicinal product on Aug 03, 2010 from UNITED STATES Additional patient health information: Female patient , 40 years of age, was diagnosed with myasthenia gravis and. Octagam dosage: 45g For 3days Q 4wks/iv.

7046823-4 | Antibiotic Resistant Staphylococcus Test Positive, Device Related Infection, Jugular Vein Thrombosis
Adverse event was reported on Aug 24, 2010 by a Male patient taking Octagam (View Usage) (Dosage: 10gm Qdx2days Q2wks Iv) was diagnosed with mitochondrial myopathy and. Location: UNITED STATES , 15 years of age, After Octagam was administered, patient had the following side effects: antibiotic resistant staphylococcus test positive, device related infection, jugular vein thrombosis. Patient was hospitalized.

7039997-2 | Hepatitis B Antibody Positive, Transmission Of An Infectious Agent Via A Medicinal Product
on Sep 08, 2010 Female patient from UNITED STATES , 40 years of age, was diagnosed with myasthenia gravis and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b antibody positive, transmission of an infectious agent via a medicinal product. Octagam dosage: 45 G.


7039866-8 | Asthenia, Blood Pressure Increased, Dizziness, Gait Disturbance, Malaise, Nausea, Pallor, Visual Impairment
on May 07, 2010 Female patient from UNITED STATES , 78 years of age, was diagnosed with polyneuropathy idiopathic progressive and was treated with Octagam (View Usage). Patient had the following side effects: asthenia, blood pressure increased, dizziness (What is dizziness?), gait disturbance, malaise, nausea (What is nausea?), pallor, visual impairment. Octagam dosage: 35gm. Patient was hospitalized.

7039380-X | Fibrin D Dimer Increased, Hyperviscosity Syndrome, Infarction, Troponin I Increased
Patient was taking Octagam (View Usage). After Octagam was administered, patient had the following side effects: fibrin d dimer increased, hyperviscosity syndrome, infarction, troponin i increased on Aug 04, 2010 from GERMANY Additional patient health information: Male patient , 71 years of age, was diagnosed with myasthenia gravis and. Octagam dosage: 400 Mg/kg. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), DELIX (HYDROCHLOROTHIAZIDE AND RAMIPRIL) (View Delix (hydrochlorothiazide And Ramipril) Review and Delix (hydrochlorothiazide And Ramipril) Label ). Patient was hospitalized.

7039349-5 | Cerebrovascular Accident, Depressed Level Of Consciousness, Hypertensive Crisis, Mydriasis, Paresis
Adverse event was reported on Aug 30, 2010 by a Male patient taking Octagam (View Usage) (Dosage: 10 G) was diagnosed with secondary immunodeficiency and. Location: GERMANY , 63 years of age, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, depressed level of consciousness, hypertensive crisis, mydriasis, paresis. During the same period patient was treated with RINGERS SOLUTION (ELECTROLYTE SUBSTITUTION) (View Ringers Solution (electrolyte Substitution) Review and Ringers Solution (electrolyte Substitution) Label ). Patient was hospitalized.

7023636-0 | Pulmonary Embolism
on Sep 30, 2010 Male patient from UNITED STATES , 43 years of age, weighting 176.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Octagam (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Octagam dosage: 400mg/kg = 35gm Daily X 5 Days Iv. Patient was hospitalized.

7023635-9 | Cerebrovascular Accident
on Sep 30, 2010 Male patient from UNITED STATES , 73 years of age, weighting 200.0 lb, was diagnosed with immune system disorder and was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: cerebrovascular accident. Octagam dosage: 30 Grams Every 2 Weeks Iv Drip. Patient was hospitalized.

7023497-X | Infusion Related Reaction, Myocardial Infarction
Patient was taking Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: infusion related reaction, myocardial infarction on Sep 29, 2010 from UNITED STATES Additional patient health information: Female patient , 69 years of age, weighting 135.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Octagam dosage: 25 Grams Daily X 5 Days Iv Drip. Patient was hospitalized.

7019614-8 | Hypertension, Product Quality Issue, Pulmonary Thrombosis
Adverse event was reported on Sep 28, 2010 by a Male patient taking Octagam (View Usage) (Dosage: 7 Per Day Once Daily Iv) was diagnosed with immune system disorder, multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 43 years of age, weighting 175.0 lb, Patient had the following side effects: hypertension, product quality issue, pulmonary thrombosis. Patient was hospitalized.

6962060-3 | Thrombophlebitis Superficial
on Sep 01, 2010 Female patient from UNITED STATES , weighting 204.0 lb, was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: thrombophlebitis superficial. Octagam dosage: .

6959419-7 | Asthma, Blood Pressure Decreased, Deep Vein Thrombosis, Heart Rate Decreased, Loss Of Consciousness, Product Quality Issue, Pulmonary Embolism
on Aug 31, 2010 Male patient from UNITED STATES , 62 years of age, weighting 270.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), blood pressure decreased, deep vein thrombosis (What is deep vein thrombosis?), heart rate decreased, loss of consciousness, product quality issue, pulmonary embolism (What is pulmonary embolism?). Octagam dosage: 120 Grams Prn Iv Drip. Patient was hospitalized.

6956955-4 | Blood Pressure Increased, Headache, Transient Ischaemic Attack, Vision Blurred
Patient was taking Octagam (View Usage). Patient had the following side effects: blood pressure increased, headache (What is headache?), transient ischaemic attack, vision blurred on Aug 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 185.0 lb, was diagnosed with myasthenia gravis and. Octagam dosage: 4 Day Infusion Iv Drip. Patient was hospitalized.

6943296-4 | Catheter Site Haemorrhage, Coma, Hypothermia, Ischaemic Stroke, Lactic Acidosis
Adverse event was reported on Jul 26, 2010 by a Male patient taking Octagam (View Usage) (Dosage: 80 G I.v.) was diagnosed with idiopathic thrombocytopenic purpura and. Location: FRANCE , 75 years of age, After Octagam was administered, patient had the following side effects: catheter site haemorrhage, coma, hypothermia (What is hypothermia?), ischaemic stroke, lactic acidosis. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FOZIRETIC (FOSINOPRIL AND HYDROCHLOROTHIAZIDE) (View Foziretic (fosinopril And Hydrochlorothiazide) Review and Foziretic (fosinopril And Hydrochlorothiazide) Label ), DESLORATADINE (View Desloratadine Review and Desloratadine Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), PERFALGAN (PARACETAMOL) (View Perfalgan (paracetamol) Review and Perfalgan (paracetamol) Label ), TOBREX (View Tobrex Review and Tobrex Label ), PLATELETS (View Platelets Review and Platelets Label ). Patient was hospitalized.

6942788-1 | Cerebrovascular Accident, Infusion Related Reaction, Neurological Symptom, Product Quality Issue
on Aug 24, 2010 Male patient from UNITED STATES , weighting 183.0 lb, was diagnosed with immunodeficiency common variable and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, infusion related reaction, neurological symptom, product quality issue. Octagam dosage: 70 Grams Every 6 Weeks Iv Drip. Patient was hospitalized and became disabled.

6942786-8 | Coronary Artery Occlusion, Infusion Related Reaction, Myocardial Infarction
on Aug 24, 2010 Male patient from UNITED STATES , 52 years of age, weighting 145.5 lb, was diagnosed with myasthenia gravis and was treated with Octagam (View Usage). Patient had the following side effects: coronary artery occlusion, infusion related reaction, myocardial infarction. Octagam dosage: 85gm Q24hx2 Q6 Weeks Iv Drip. Patient was hospitalized.

6924404-8 | Deep Vein Thrombosis, Fatigue, Headache, Muscular Weakness, Nausea, Pulmonary Embolism
Patient was taking Octagam (View Usage). After Octagam was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), fatigue, headache (What is headache?), muscular weakness, nausea (What is nausea?), pulmonary embolism (What is pulmonary embolism?) on Jul 12, 2010 from UNITED STATES Additional patient health information: Male patient , 67 years of age, weighting 235.9 lb, was diagnosed with demyelinating polyneuropathy and. Octagam dosage: 120gm Iv Every 3 Weeks. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), CLARITIN (View Claritin Review and Claritin Label ), ASTELIN (View Astelin Review and Astelin Label ), FLONASE (View Flonase Review and Flonase Label ), SUDAFED S.A. (View Sudafed S.a. Review and Sudafed S.a. Label ), BENADRYL (View Benadryl Review and Benadryl Label ). Patient was hospitalized.

6896550-9 | Infusion Related Reaction, Myocardial Infarction, Unresponsive To Stimuli
Adverse event was reported on Jul 07, 2010 by a Male patient taking Octagam (View Usage) (Dosage: 100gm Q3wks, Iv) was diagnosed with myasthenia gravis and. Location: UNITED STATES , 64 years of age, Patient experienced the following unwanted or unexpected effects: infusion related reaction, myocardial infarction, unresponsive to stimuli. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), AMARYL (View Amaryl Review and Amaryl Label ), AVANDIA (ROSIGLITAZONE MALEAT) (View Avandia (rosiglitazone Maleat) Review and Avandia (rosiglitazone Maleat) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), MESTINON (PYRIDOSTIGMINE) (View Mestinon (pyridostigmine) Review and Mestinon (pyridostigmine) Label ).

6761723-2 | Abdominal Pain Upper, Alanine Aminotransferase Increased, Anaemia, Anti-hbc Antibody Positive, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gastrointestinal Haemorrhage, Hepatitis B Surface Antigen Positive, Hepatitis C Antibody Positive
on Apr 08, 2010 Male patient from SPAIN , 66 years of age, was diagnosed with immunodeficiency and was treated with Octagam (View Usage). Patient had the following side effects: abdominal pain upper, alanine aminotransferase increased, anaemia, anti-hbc antibody positive, aspartate aminotransferase increased, blood alkaline phosphatase increased, gastrointestinal haemorrhage, hepatitis b surface antigen positive, hepatitis c antibody positive. Octagam dosage: 30 G I.v..

6761715-3 | Cough, Dyspnoea, Laryngeal Oedema
on Apr 19, 2010 Female patient from PORTUGAL , 62 years of age, was diagnosed with immunodeficiency common variable and was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: cough, dyspnoea, laryngeal oedema. Octagam dosage: I.v.. During the same period patient was treated with CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), 80 % (PROPRANOLOL) (View 80 % (propranolol) Review and 80 % (propranolol) Label ), URSODIOL (View Ursodiol Review and Ursodiol Label ).

6719128-6 | Blood Pressure Fluctuation, Blood Pressure Increased, Myocardial Infarction
Patient was taking Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure fluctuation, blood pressure increased, myocardial infarction on May 10, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 128.0 lb, was diagnosed with humoral immune defect, selective igg subclass deficiency and. Octagam dosage: 20 Grams Qmonth Iv Drip. During the same period patient was treated with DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), MEDROL (View Medrol Review and Medrol Label ), OXYBUTYNIN PATCH (View Oxybutynin Patch Review and Oxybutynin Patch Label ), ENABLEX (View Enablex Review and Enablex Label ), APSIRIN (View Apsirin Review and Apsirin Label ). Patient was hospitalized.

6716224-4 | Cerebrovascular Accident, Confusional State, Hallucination, Visual, Headache, Infusion Related Reaction, Retching, Sluggishness, Urinary Tract Infection
Adverse event was reported on May 06, 2010 by a Female patient taking Octagam (View Usage) (Dosage: 40 Grams Gmonth Iv Drip) was diagnosed with immunodeficiency common variable and. Location: UNITED STATES , weighting 210.0 lb, Patient had the following side effects: cerebrovascular accident, confusional state, hallucination, visual, headache (What is headache?), infusion related reaction, retching, sluggishness, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), POTASSIUM (View Potassium Review and Potassium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ), MULTIGEN (View Multigen Review and Multigen Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), AVALIDE (View Avalide Review and Avalide Label ). Patient was hospitalized.

6708832-1 | Asthenia, Blood Pressure Increased, Cerebrovascular Accident, Confusional State, Dizziness, Infusion Related Reaction, Movement Disorder, Vomiting
on May 03, 2010 Female patient from UNITED STATES , weighting 152.1 lb, was diagnosed with dermatomyositis and was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: asthenia, blood pressure increased, cerebrovascular accident, confusional state, dizziness (What is dizziness?), infusion related reaction, movement disorder (What is movement disorder?), vomiting. Octagam dosage: 5 Grams Daily X 2days Q2w Iv Drip. During the same period patient was treated with DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), DRISDOL (View Drisdol Review and Drisdol Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6668802-9 | Cerebellar Infarction, Hyperviscosity Syndrome
on Mar 15, 2010 Male patient from AUSTRALIA , 74 years of age, was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: cerebellar infarction, hyperviscosity syndrome. Octagam dosage: I.v..

6668800-5 | Chills, Flushing, Headache, Heart Rate Increased, Infusion Related Reaction, Oxygen Saturation Decreased, Pyrexia
Patient was taking Octagam (View Usage). Patient had the following side effects: chills, flushing, headache (What is headache?), heart rate increased, infusion related reaction, oxygen saturation decreased, pyrexia on Mar 15, 2010 from AUSTRALIA Additional patient health information: Female patient , 41 years of age, was diagnosed with lymphoma (What is lymphoma?) and. Octagam dosage: 24 G I.v.. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), MORPHINE (View Morphine Review and Morphine Label ), PIPERACILLIN AND TAZOBACTAM (View Piperacillin And Tazobactam Review and Piperacillin And Tazobactam Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ).

6668785-1 | Aphasia, Ataxia, Bradyphrenia, Condition Aggravated, Confusional State, Dyskinesia
Adverse event was reported on Mar 05, 2010 by a Male patient taking Octagam (View Usage) (Dosage: 30 G I.v.) was diagnosed with primary immunodeficiency syndrome and. Location: UNITED KINGDOM , 66 years of age, After Octagam was administered, patient had the following side effects: aphasia (What is aphasia?), ataxia (What is ataxia?), bradyphrenia, condition aggravated, confusional state, dyskinesia. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), QVAR 80 (View Qvar 80 Review and Qvar 80 Label ), NASONEX (MOMETASONE) (View Nasonex (mometasone) Review and Nasonex (mometasone) Label ), PERSANTIN (View Persantin Review and Persantin Label ).

6656762-6 | Hepatitis B
on Mar 03, 2010 Female patient from UNITED STATES , 35 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis b (What is hepatitis b?). Octagam dosage: 40 Gm Iv Every 2 Weeks.

6653868-2 | Chills, Dyspnoea, Pneumonia
on Mar 01, 2010 Female patient from GERMANY , 81 years of age, was diagnosed with secondary immunodeficiency and was treated with Octagam (View Usage). Patient had the following side effects: chills, dyspnoea, pneumonia (What is pneumonia?). Octagam dosage: 15 G Iv. During the same period patient was treated with HUMAN RED BLOOD CELLS (View Human Red Blood Cells Review and Human Red Blood Cells Label ), ERYPO (EPOETIN ALFA) (View Erypo (epoetin Alfa) Review and Erypo (epoetin Alfa) Label ), DIPYRONE TAB (View Dipyrone Tab Review and Dipyrone Tab Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), IBANDRONATE SODIUM (View Ibandronate Sodium Review and Ibandronate Sodium Label ), ISOKET RETARD (ISOSORBIDE DINITRATE (View Isoket Retard (isosorbide Dinitrate Review and Isoket Retard (isosorbide Dinitrate Label ), IMMUNE GLOBULIN (HUMAN) (View Immune Globulin (human) Review and Immune Globulin (human) Label ). Patient was hospitalized.

6607595-8 | Hepatitis B
Patient was taking Octagam (View Usage). After Octagam was administered, patient had the following side effects: hepatitis b (What is hepatitis b?) on Feb 02, 2010 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Octagam dosage: 40 Gm Iv Every 2 Weeks.

6607426-6 | Hepatic Failure
Adverse event was reported on Jan 20, 2010 by a Male patient taking Octagam (View Usage) (Dosage: 50 G I.v.) was diagnosed with idiopathic thrombocytopenic purpura and. Location: PORTUGAL , 62 years of age, Patient experienced the following unwanted or unexpected effects: hepatic failure. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), METFORMIN (View Metformin Review and Metformin Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

6486537-2 | Cardiac Arrest
on Oct 29, 2009 Male patient from AUSTRALIA , 70 years of age, was diagnosed with guillain-barre syndrome (What is guillain-barre syndrome?) and was treated with Octagam (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?). Octagam dosage: 40 G. During the same period patient was treated with PERINDOPRIL (View Perindopril Review and Perindopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ).

6461579-1 | Anxiety, Condition Aggravated, Dyspnoea, Malaise, Myalgia, Pyrexia, Tachycardia
on Nov 04, 2009 Male patient from UNITED STATES , 40 years of age, was diagnosed with autonomic nervous system imbalance and was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: anxiety (What is anxiety?), condition aggravated, dyspnoea, malaise, myalgia, pyrexia, tachycardia. Octagam dosage: 25 Gm Daily For 5 Days. Patient was hospitalized.

6436782-7 | Arteriovenous Fistula Thrombosis, Dialysis
Patient was taking Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: arteriovenous fistula thrombosis, dialysis (What is dialysis?) on Oct 16, 2009 from AUSTRALIA Additional patient health information: Male patient , 48 years of age, was diagnosed with kidney transplant rejection and. Octagam dosage: 80 G I.v..

6436780-3 | Arteriovenous Fistula Thrombosis, Pain, Swelling
Adverse event was reported on Oct 16, 2009 by a Male patient taking Octagam (View Usage) (Dosage: 90 G I.v.) was diagnosed with kidney transplant rejection and. Location: AUSTRALIA , 41 years of age, weighting 205.0 lb, Patient had the following side effects: arteriovenous fistula thrombosis, pain (What is pain?), swelling. During the same period patient was treated with OCTAGAM 5 %IIIIIIIII (HUMAN NORMAL IMMUNOGLOBULIN) (View Octagam 5 %iiiiiiiii (human Normal Immunoglobulin) Review and Octagam 5 %iiiiiiiii (human Normal Immunoglobulin) Label ). Patient was hospitalized.

6436726-8 | Arteriovenous Fistula Thrombosis
on Oct 16, 2009 Male patient from AUSTRALIA , 41 years of age, weighting 132.3 lb, was diagnosed with kidney transplant rejection and was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: arteriovenous fistula thrombosis. Octagam dosage: 60 G I.v.. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PHENERGAN (PROMETHAZINE) (View Phenergan (promethazine) Review and Phenergan (promethazine) Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ).

6436721-9 | Arteriovenous Fistula Thrombosis, Kidney Transplant Rejection
on Oct 16, 2009 Male patient from AUSTRALIA , 56 years of age, weighting 183.0 lb, was diagnosed with kidney transplant rejection and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: arteriovenous fistula thrombosis, kidney transplant rejection. Octagam dosage: 80 G I.v..

6406211-8 | Convulsion, Enterobacter Sepsis, Transmission Of An Infectious Agent Via A Medicinal Product
Patient was taking Octagam (View Usage). Patient had the following side effects: convulsion, enterobacter sepsis, transmission of an infectious agent via a medicinal product on Sep 18, 2009 from AUSTRALIA Additional patient health information: Female patient , child 11 years of age, was diagnosed with nervous system disorder and. Octagam dosage: 40 G I.v.. During the same period patient was treated with METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ).

6398668-6 | Convulsion, Enterobacter Sepsis, Transmission Of An Infectious Agent Via A Medicinal Product
Adverse event was reported on Sep 05, 2009 by a Female patient taking Octagam (View Usage) (Dosage: 40 G I.v.) was diagnosed with nervous system disorder and. Location: AUSTRALIA , child 11 years of age, After Octagam was administered, patient had the following side effects: convulsion, enterobacter sepsis, transmission of an infectious agent via a medicinal product. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6369199-4 | Htlv-1 Test Positive, Htlv-2 Test Positive, Transmission Of An Infectious Agent Via A Medicinal Product
on Aug 26, 2009 Male patient from AUSTRALIA , 46 years of age, was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: htlv-1 test positive, htlv-2 test positive, transmission of an infectious agent via a medicinal product. Octagam dosage: I.v..

6327827-3 | Neutropenia, White Blood Cell Count Decreased
on Aug 04, 2009 Female patient from AUSTRIA , 58 years of age, was treated with Octagam (View Usage). Patient had the following side effects: neutropenia, white blood cell count decreased. Octagam dosage: I.v.. Patient was hospitalized.

6276006-7 | Hepatitis B Antibody Positive, Immunisation, Transmission Of An Infectious Agent Via A Medicinal Product
Patient was taking Octagam (View Usage). After Octagam was administered, patient had the following side effects: hepatitis b antibody positive, immunisation, transmission of an infectious agent via a medicinal product on Jun 29, 2009 from FRANCE Additional patient health information: Male patient , 57 years of age, was diagnosed with transplant rejection and. Octagam dosage: I.v.. During the same period patient was treated with RED BLOOD CELLS (I.v.) (View Red Blood Cells Review and Red Blood Cells Label ), ALBUMIN (HUMAN) (View Albumin (human) Review and Albumin (human) Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), PROGRAF (View Prograf Review and Prograf Label ), ROVALCYTE (VALGANCICLOVIR) (View Rovalcyte (valganciclovir) Review and Rovalcyte (valganciclovir) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), SECTRAL (View Sectral Review and Sectral Label ).

6273152-9 | Acute Myocardial Infarction
Adverse event was reported on Jun 24, 2009 by a Male patient taking Octagam (View Usage) (Dosage: 50 G I.v.) was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and. Location: AUSTRIA , 55 years of age, Patient experienced the following unwanted or unexpected effects: acute myocardial infarction. Patient was hospitalized.

6260572-1 | Extrasystoles, Heart Rate Decreased, Infusion Related Reaction
on Jun 11, 2009 Male patient from AUSTRALIA , 49 years of age, was diagnosed with chronic inflammatory demyelinating polyradiculoneuropathy and was treated with Octagam (View Usage). Patient had the following side effects: extrasystoles, heart rate decreased, infusion related reaction. Octagam dosage: . Patient was hospitalized.

6220299-9 | Neuropathy Peripheral
on May 19, 2009 Male patient from UNITED KINGDOM , 45 years of age, was diagnosed with aplasia pure red cell, tuberculosis (What is tuberculosis?) and was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: neuropathy peripheral. Octagam dosage: 80 G I.v.. Patient was hospitalized.

6220280-X | Hepatitis A Antibody Positive, Hepatitis B Antibody Positive
Patient was taking Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis a antibody positive, hepatitis b antibody positive on May 18, 2009 from UNITED STATES Additional patient health information: Female patient , 39 years of age, was diagnosed with autoimmune disorder and. Octagam dosage: 25 Gm Every Month Iv.

6198002-0 | Hepatitis A Antibody Positive, Hepatitis B Antibody Positive
Adverse event was reported on Apr 29, 2009 by a Female patient taking Octagam (View Usage) (Dosage: 25 Gm Every Month Iv) was diagnosed with autoimmune disorder, habitual abortion and. Location: UNITED STATES , 39 years of age, Patient had the following side effects: hepatitis a antibody positive, hepatitis b antibody positive.

6181728-2 | Hepatitis B Antibody Positive, Transmission Of An Infectious Agent Via A Medicinal Product
on Apr 17, 2009 Female patient from AUSTRALIA , 29 years of age, was diagnosed with antiphospholipid syndrome and was treated with Octagam (View Usage). After Octagam was administered, patient had the following side effects: hepatitis b antibody positive, transmission of an infectious agent via a medicinal product. Octagam dosage: 67.5 G; I.v.. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

6180904-2 | Neutropenia, White Blood Cell Count Decreased
on Apr 14, 2009 Female patient from FRANCE , 80 years of age, was diagnosed with polyneuropathy and was treated with Octagam (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia, white blood cell count decreased. Octagam dosage: 30 G I.v.. Patient was hospitalized.

6170157-3 | Meningitis Aseptic
Patient was taking Octagam (View Usage). Patient had the following side effects: meningitis aseptic on Apr 27, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 160.0 lb, was diagnosed with dermatomyositis and. Octagam dosage: .